These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17286034)

  • 1. [Assessment of compliance with ARV treatment in Africa].
    Mouala C; Roux P; Okome M; Sentenac S; Okome F; Nziengui U; Olivier F; Benjaber K; Rey JL
    Med Trop (Mars); 2006 Dec; 66(6):610-4. PubMed ID: 17286034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Measuring treatment compliance in patients with HIV in Bangui, Central African Republic].
    Mouala C; Kaba-Mebri J; Fikouma V; Wata JB; Gabrie P; Rey JL
    Med Trop (Mars); 2006 Feb; 66(1):59-63. PubMed ID: 16615617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Factors associated with adherence to therapy among HIV-infected patients in Bangui].
    Mouala C; Kaba-Mebri J; Wata JB; Rey JL
    Sante; 2006; 16(2):119-30. PubMed ID: 17116636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of non-adherence to subsidized anti-retroviral treatment in southeast Nigeria.
    Uzochukwu BS; Onwujekwe OE; Onoka AC; Okoli C; Uguru NP; Chukwuogo OI
    Health Policy Plan; 2009 May; 24(3):189-96. PubMed ID: 19276155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa.
    Harries AD; Zachariah R; Lawn SD
    Int J Tuberc Lung Dis; 2009 Jan; 13(1):6-16. PubMed ID: 19105873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cotrimoxazole prophylaxis for HIV-positive TB patients in developing countries.
    Zachariah R; Massaquoi M
    Trop Doct; 2006 Apr; 36(2):79-82. PubMed ID: 16611438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-associated Isospora belli infection: incidence and risk factors in the French Hospital Database on HIV.
    Guiguet M; Furco A; Tattevin P; Costagliola D; Molina JM;
    HIV Med; 2007 Mar; 8(2):124-30. PubMed ID: 17352769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Observance of antiretroviral treatments: African specificities].
    Eholié SP; N'dour CT; Cissé M; Bissagnéné E; Girard PM
    Med Mal Infect; 2006 Sep; 36(9):443-8. PubMed ID: 17027212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Time is costly': modelling the macroeconomic impact of scaling-up antiretroviral treatment in sub-Saharan Africa.
    Ventelou B; Moatti JP; Videau Y; Kazatchkine M
    AIDS; 2008 Jan; 22(1):107-13. PubMed ID: 18090398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Severe opportunistic infections in HIV-positive adults in sub-Saharan Africa].
    Anglaret X
    Med Trop (Mars); 2006 Aug; 66(4):343-5. PubMed ID: 16999042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Payment for antiretroviral drugs is associated with a higher rate of patients lost to follow-up than those offered free-of-charge therapy in Nairobi, Kenya.
    Zachariah R; Van Engelgem I; Massaquoi M; Kocholla L; Manzi M; Suleh A; Phillips M; Borgdorff M
    Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):288-93. PubMed ID: 18258272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral treatment adherence and its correlates in Addis Ababa, Ethiopia.
    Tadios Y; Davey G
    Ethiop Med J; 2006 Jul; 44(3):237-44. PubMed ID: 17447389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-trimoxazole prophylaxis in tropical countries in the era of highly active antiretroviral therapy: do we know enough?
    Lynen L; Jacobs J; Colebunders R
    Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1059-60. PubMed ID: 17662321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study on antiretroviral treatment compliance in Casablanca (Morocco)].
    Benjaber K; Rey JL; Himmich H
    Med Mal Infect; 2005; 35(7-8):390-5. PubMed ID: 15982843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya.
    Karcher H; Omondi A; Odera J; Kunz A; Harms G
    Trop Med Int Health; 2007 May; 12(5):687-94. PubMed ID: 17445136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [AIDS treatment in Africa: the risk of antiretroviral resistance].
    Hamers RL; Schuurman R; van Vugt M; Derdelinckx I; Rinke de Wit TF
    Ned Tijdschr Geneeskd; 2007 Dec; 151(48):2666-71. PubMed ID: 18179083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited.
    Orrell C; Harling G; Lawn SD; Kaplan R; McNally M; Bekker LG; Wood R
    Antivir Ther; 2007; 12(1):83-8. PubMed ID: 17503751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of appropriate treatment for people with comorbid HIV/AIDS and epilepsy in sub-Saharan Africa.
    Birbeck G; Chomba E; Ddumba E; Kauye F; Mielke J
    Epilepsia; 2007 Jul; 48(7):1424-5. PubMed ID: 17635568
    [No Abstract]   [Full Text] [Related]  

  • 19. Compliance with anti-infective preventive measures: A multicentre survey among paediatric oncology patients.
    Lehrnbecher T; Laws HJ; Boehm A; Dworzak M; Janssen G; Simon A; Groll AH
    Eur J Cancer; 2008 Sep; 44(13):1861-5. PubMed ID: 18662870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction: the realities of antiretroviral therapy rollout: overcoming challenges to successful programmatic implementation.
    Ojikutu B
    J Infect Dis; 2007 Dec; 196 Suppl 3():S445-8. PubMed ID: 18181692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.